Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy
- PMID: 17897122
- DOI: 10.1111/j.1540-8159.2007.00841.x
Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy
Abstract
Objectives: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT).
Methods: Sixty-two patients with heart failure (age 67.3 +/- 9.6 yrs [mean +/- SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS > or = 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) for scar imaging. Patients were followed up for 741 (75-1602) days (mean [range]).
Results: The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by > or =1 NYHA classes or > or =25% in 6-min walking distance) was 83% in the group with non-PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05).
Conclusions: A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium.
Similar articles
-
Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.Europace. 2009 Apr;11(4):495-501. doi: 10.1093/europace/eup037. Europace. 2009. PMID: 19307283
-
Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.J Am Coll Cardiol. 2007 Jul 17;50(3):243-52. doi: 10.1016/j.jacc.2007.03.035. Epub 2007 Jun 29. J Am Coll Cardiol. 2007. PMID: 17631217
-
Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S186-9. doi: 10.1111/j.1540-8159.2008.02280.x. Pacing Clin Electrophysiol. 2009. PMID: 19250090 Clinical Trial.
-
Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Interact Cardiovasc Thorac Surg. 2008. PMID: 18541605 Review.
-
Cardiac resynchronization therapy in heart failure patients: an update.Cardiol J. 2009;16(3):197-209. Cardiol J. 2009. PMID: 19437393 Review.
Cited by
-
Speckle tracking echocardiography: clinical applications in cardiac resynchronization therapy.Int J Clin Exp Med. 2015 May 15;8(5):6668-76. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221204 Free PMC article. Review.
-
Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position.J Interv Card Electrophysiol. 2012 Mar;33(2):151-60. doi: 10.1007/s10840-011-9630-9. Epub 2011 Nov 30. J Interv Card Electrophysiol. 2012. PMID: 22127378
-
ECG Patterns In Cardiac Resynchronization Therapy.J Atr Fibrillation. 2015 Apr 30;7(6):1214. doi: 10.4022/jafib.1214. eCollection 2015 Apr-May. J Atr Fibrillation. 2015. PMID: 27957163 Free PMC article. Review.
-
Non-contrast magnetic resonance imaging for guiding left ventricular lead position in cardiac resynchronization therapy.J Interv Card Electrophysiol. 2012 Jan;33(1):27-35. doi: 10.1007/s10840-011-9599-4. Epub 2011 Jul 19. J Interv Card Electrophysiol. 2012. PMID: 21769665
-
Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy.Korean Circ J. 2020 Dec;50(12):1062-1073. doi: 10.4070/kcj.2019.0420. Epub 2020 Oct 7. Korean Circ J. 2020. PMID: 33150752 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials